Clinical Trial Update: Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating arzoxifene or tamoxifen for breast cancer prevention in high-risk premenopausal women has completed. The study was sponsored by The C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hereditary Breast and Ovarian Cancer Syndrome

Drugs mentioned

• Arzoxifene (arzoxifene)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Breast Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2) | Phase 2 | Status: COMPLETED